Hyungwoo Cho

8PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Transplantation immunologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 12, 2026
Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01).

|May 29, 2026
Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry.

|Sep 30, 2025
Clonal Burden, Immunoglobulin Heavy Chain Variable Gene Somatic Hypermutations, and Immunoglobulin Gene Repertoire in Korean Patients with Chronic Lymphocytic Leukemia Assessed by Next-generation Sequencing.

Taegeun Lee, Daehyun Chu, Miyoung Kim

|Jul 24, 2024
Immunity Against Measles in Korean Autologous Hematopoietic Stem Cell Transplant Recipients.

Hyeon Mu Jang, Seongman Bae, Jiwon Jung

|Aug 22, 2021
Prognostic value of natural killer cell activity for patients with HER2 + advanced gastric cancer treated with first-line fluoropyrimidine-platinum doublet plus trastuzumab.

Hyungwoo Cho, Min-Hee Ryu, Hyung Eun Lee

|Mar 29, 2021
The limited role of comprehensive staging work-up in ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type (MALToma) with excellent prognosis.

Heejung Chae, Hyungwoo Cho, Ho-Seok Sa

Pageof 2

Frequent Collaborators

4 joint publications

Dok Hyun Yoon

2 joint publications

Chan-Sik Park

2 joint publications

Seongsoo Jang

1 joint publications

Jin Seok Kim